Imraan Munshi | Executive Director And Global Communications Lead For Vaccines
Merck & Co Inc | United States

Imraan Munshi, Executive Director And Global Communications Lead For Vaccines, Merck & Co Inc

Imraan Munshi is Global Communications Lead – Vaccines for Merck & Co, Inc. (Merck) leading the development and implementation of global communications strategies and programs in support of the Company’s vaccine brands, portfolios and investigational vaccines. Munshi develops and conducts vaccine confidence and social media workshops across stakeholder networks for the company and serves as counselor, leader and key resource to senior executives, regions and subsidiaries for product and executive communications.

Before joining MSD in 2012, Munshi was senior director of Pfizer’s Policy, External Affairs and Communications group and communications lead for the Emerging Markets Business Unit. He relocated from Johannesburg, South Africa to New York, where he was appointed senior director in Worldwide Communications and supported businesses in Japan/Asia, Canada, Latin America, Africa and the Middle East.

In his previous role as public affairs director for Pfizer Southern Africa, Munshi led government relations, external affairs, drug/medicines access, corporate citizenship, internal communications and media affairs for the region. He has also served as a radio and television sports anchor on International Cricket for the national broadcasting service in South Africa.


Oct 30th Day 2 @ 09:05

Pandemic preparedness - How to proceed in the absence of an outbreak?

Examples from Ebola and Zika

Oct 31st Day 3 @ 09:10

Panel: Building vaccine confidence and resilient immunization systems – The role of communications

The role of communications in vaccine hesitancy andconfidence?-How can stakeholdersfrom patient advocates, journalists, healthcare providers, policymakers to industry – apply behavioral science insights to shape more effective communications around vaccination and improve vaccination acceptance?-What are the attributes of a resilient immunization system, and how can we collaborate to manage threats to vaccine confidence and better anticipate and mitigate issues in the future?
last published: 16/Sep/19 14:05 GMT

back to speakers

Sign Up for Event Updates